These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37682599)

  • 1. Detailed Assessment of 18F-THK5351 Distribution Pattern in the Midbrain: Comparison With Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Ishibashi K; Kurihara M; Ihara R; Higashihara M; Iwata A; Ishii K
    Clin Nucl Med; 2023 Oct; 48(10):841-846. PubMed ID: 37682599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimaging-pathological correlations of [
    Ishiki A; Harada R; Kai H; Sato N; Totsune T; Tomita N; Watanuki S; Hiraoka K; Ishikawa Y; Funaki Y; Iwata R; Furumoto S; Tashiro M; Sasano H; Kitamoto T; Kudo Y; Yanai K; Furukawa K; Okamura N; Arai H
    Acta Neuropathol Commun; 2018 Jun; 6(1):53. PubMed ID: 29958546
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Ezura M; Kikuchi A; Okamura N; Ishiki A; Hasegawa T; Harada R; Watanuki S; Funaki Y; Hiraoka K; Baba T; Sugeno N; Yoshida S; Kobayashi J; Kobayashi M; Tano O; Ishiyama S; Nakamura T; Nakashima I; Mugikura S; Iwata R; Taki Y; Furukawa K; Arai H; Furumoto S; Tashiro M; Yanai K; Kudo Y; Takeda A; Aoki M
    Front Aging Neurosci; 2021; 13():761010. PubMed ID: 34912209
    [No Abstract]   [Full Text] [Related]  

  • 4. PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers.
    Vasilevskaya A; Taghdiri F; Multani N; Anor C; Misquitta K; Houle S; Burke C; Tang-Wai D; Lang AE; Fox S; Slow E; Rusjan P; Tartaglia MC
    Front Neurol; 2020; 11():574. PubMed ID: 32754109
    [No Abstract]   [Full Text] [Related]  

  • 5. Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [
    Ng KP; Therriault J; Kang MS; Struyfs H; Pascoal TA; Mathotaarachchi S; Shin M; Benedet AL; Massarweh G; Soucy JP; Rosa-Neto P; Gauthier S
    Neuroimage Clin; 2019; 24():102091. PubMed ID: 31795034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Brendel M; Schönecker S; Höglinger G; Lindner S; Havla J; Blautzik J; Sauerbeck J; Rohrer G; Zach C; Vettermann F; Lang AE; Golbe L; Nübling G; Bartenstein P; Furukawa K; Ishiki A; Bötzel K; Danek A; Okamura N; Levin J; Rominger A
    Front Aging Neurosci; 2017; 9():440. PubMed ID: 29387005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias.
    Silsby M; Tweedie-Cullen RY; Murray CR; Halliday GM; Hodges JR; Burrell JR
    Eur J Neurol; 2017 Jul; 24(7):956-965. PubMed ID: 28510312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration.
    Koga S; Metrick MA; Golbe LI; Santambrogio A; Kim M; Soto-Beasley AI; Walton RL; Baker MC; De Castro CF; DeTure M; Russell D; Navia BA; Sandiego C; Ross OA; Vendruscolo M; Caughey B; Dickson DW
    Acta Neuropathol Commun; 2023 Jun; 11(1):88. PubMed ID: 37264457
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Liu FT; Lu JY; Li XY; Jiao FY; Chen MJ; Yao RX; Liang XN; Ju ZZ; Ge JJ; Li G; Shen B; Wu P; Song J; Li J; Sun YM; Wu JJ; Yen TC; Luo JF; Zhao QH; Zuo C; Wang J;
    Mov Disord; 2023 Apr; 38(4):579-588. PubMed ID: 36750757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution Pattern of the Monoamine Oxidase B Ligand, 18F-THK5351, in the Healthy Brain.
    Ishibashi K; Miura Y; Tago T; Toyohara J; Higashihara M; Iwata A; Ishii K
    Clin Nucl Med; 2022 Jul; 47(7):e489-e495. PubMed ID: 35675140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology.
    Whitwell JL; Jack CR; Parisi JE; Gunter JL; Weigand SD; Boeve BF; Ahlskog JE; Petersen RC; Dickson DW; Josephs KA
    Eur J Neurol; 2013 Oct; 20(10):1417-22. PubMed ID: 23746093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson's syndrome.
    Sakurai K; Imabayashi E; Tokumaru AM; Hasebe S; Murayama S; Morimoto S; Kanemaru K; Takao M; Shibamoto Y; Matsukawa N
    Neuroimage Clin; 2015; 7():605-10. PubMed ID: 26082887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau Imaging in the 4-Repeat-Tauopathies Progressive Supranuclear Palsy and Corticobasal Syndrome: A 11C-Pyridinyl-Butadienyl-Benzothiazole 3 PET Pilot Study.
    Schröter N; Blazhenets G; Frings L; Barkhausen C; Jost WH; Weiller C; Rijntjes M; Meyer PT
    Clin Nucl Med; 2020 Apr; 45(4):283-287. PubMed ID: 32108694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy.
    Brendel M; Barthel H; van Eimeren T; Marek K; Beyer L; Song M; Palleis C; Gehmeyr M; Fietzek U; Respondek G; Sauerbeck J; Nitschmann A; Zach C; Hammes J; Barbe MT; Onur O; Jessen F; Saur D; Schroeter ML; Rumpf JJ; Rullmann M; Schildan A; Patt M; Neumaier B; Barret O; Madonia J; Russell DS; Stephens A; Roeber S; Herms J; Bötzel K; Classen J; Bartenstein P; Villemagne V; Levin J; Höglinger GU; Drzezga A; Seibyl J; Sabri O
    JAMA Neurol; 2020 Nov; 77(11):1408-1419. PubMed ID: 33165511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Pantelyat A
    Continuum (Minneap Minn); 2022 Oct; 28(5):1364-1378. PubMed ID: 36222770
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Hsu JL; Chen SH; Hsiao IT; Lu CS; Yen TC; Okamura N; Lin KJ; Weng YH
    Sci Rep; 2020 Nov; 10(1):19410. PubMed ID: 33173080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome.
    Ahn JH; Kim M; Kim JS; Youn J; Jang W; Oh E; Lee PH; Koh SB; Ahn TB; Cho JW
    Parkinsonism Relat Disord; 2019 Sep; 66():80-86. PubMed ID: 31307918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.
    Ling H; de Silva R; Massey LA; Courtney R; Hondhamuni G; Bajaj N; Lowe J; Holton JL; Lees A; Revesz T
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):149-63. PubMed ID: 23432126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network connectivity and structural correlates of survival in progressive supranuclear palsy and corticobasal syndrome.
    Whiteside DJ; Street D; Murley AG; Jones PS; Malpetti M; Ghosh BCP; Coyle-Gilchrist I; Gerhard A; Hu MT; Klein JC; Leigh PN; Church A; Burn DJ; Morris HR; Rowe JB; Rittman T
    Hum Brain Mapp; 2023 Aug; 44(11):4239-4255. PubMed ID: 37269181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis.
    Lyons S; Trépel D; Lynch T; Walsh R; O'Dowd S
    J Neurol; 2023 Sep; 270(9):4451-4465. PubMed ID: 37289323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.